$STLY
HG Holdings Inc

2020 Form 10-K Financial Statement

#000143774921004617 Filed on March 01, 2021

View on sec.gov

Income Statement

Concept 2020 2019 Q4 2019
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $1.304M $372.0K $1.133M
YoY Change 15.09% 62.45% 12.74%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.000K $1.000K $2.000K
YoY Change 50.0% 100.0%
% of Gross Profit
Operating Expenses $1.304M $372.0K $1.133M
YoY Change 15.09% 62.45% 12.74%
Operating Profit -$1.304M -$1.133M
YoY Change 15.09% 12.74%
Interest Expense $874.0K $137.0K $886.0K
YoY Change -1.35% -57.85% -6.04%
% of Operating Profit
Other Income/Expense, Net $1.367M
YoY Change
Pretax Income $63.00K -$235.0K $86.00K
YoY Change -26.74% -292.62% -76.69%
Income Tax $0.00 $0.00 -$84.00K
% Of Pretax Income 0.0% -97.67%
Net Earnings $63.00K -$235.0K $170.0K
YoY Change -62.94% -292.62% -111.81%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 -$16.19K $136.6K
COMMON SHARES
Basic Shares Outstanding 2.083M 14.85M 14.51M
Diluted Shares Outstanding 2.118M 14.94M

Balance Sheet

Concept 2020 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.40M $2.567M $2.567M
YoY Change 343.94% -57.62% -57.62%
Cash & Equivalents $2.800M
Short-Term Investments
Other Short-Term Assets $373.0K $409.0K $409.0K
YoY Change -8.8% -39.59% -39.59%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.56M $3.802M $3.802M
YoY Change 230.22% -47.36% -47.36%
LONG-TERM ASSETS
Property, Plant & Equipment $7.000K $7.000K $7.000K
YoY Change 0.0% -22.22% -22.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.07M $4.405M $4.405M
YoY Change 174.05%
Other Assets $509.0K $494.0K $741.0K
YoY Change -31.31% 2.92% -23.92%
Total Long-Term Assets $14.47M $10.53M $10.53M
YoY Change 37.4% 53.42% 53.42%
TOTAL ASSETS
Total Short-Term Assets $12.56M $3.802M $3.802M
Total Long-Term Assets $14.47M $10.53M $10.53M
Total Assets $27.03M $14.33M $14.33M
YoY Change 88.54% 1.75% 1.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.000K $7.000K $7.000K
YoY Change -57.14% -75.86% -75.86%
Accrued Expenses $60.00K $173.0K $173.0K
YoY Change -65.32% 36.22% 36.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $63.00K $180.0K $180.0K
YoY Change -65.0% 15.38% 15.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $243.0K $255.0K $255.0K
YoY Change -4.71% -11.15% -11.15%
Total Long-Term Liabilities $243.0K $255.0K $255.0K
YoY Change -4.71% -11.15% -11.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $63.00K $180.0K $180.0K
Total Long-Term Liabilities $243.0K $255.0K $255.0K
Total Liabilities $306.0K $435.0K $435.0K
YoY Change -29.66% -1.81% -1.81%
SHAREHOLDERS EQUITY
Retained Earnings -$3.765M
YoY Change -4.32%
Common Stock $17.66M
YoY Change 0.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.72M $13.64M $13.90M
YoY Change
Total Liabilities & Shareholders Equity $27.03M $14.33M $14.33M
YoY Change 88.54% 1.75% 1.75%

Cashflow Statement

Concept 2020 2019 Q4 2019
OPERATING ACTIVITIES
Net Income $63.00K -$235.0K $170.0K
YoY Change -62.94% -292.62% -111.81%
Depreciation, Depletion And Amortization $3.000K $1.000K $2.000K
YoY Change 50.0% 100.0%
Cash From Operating Activities $290.0K -$12.00K $1.395M
YoY Change -79.21% -123.08% -131.67%
INVESTING ACTIVITIES
Capital Expenditures $3.000K
YoY Change
Acquisitions $0.00
YoY Change
Other Investing Activities -$4.132M $565.0K -$5.056M
YoY Change -18.28% -2048.28% -154.96%
Cash From Investing Activities -$4.135M $565.0K -$5.056M
YoY Change -18.22% -1983.33% -155.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $12.68M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $12.68M
YoY Change
NET CHANGE
Cash From Operating Activities $290.0K -12.00K 1.395M
Cash From Investing Activities -$4.135M 565.0K -5.056M
Cash From Financing Activities $12.68M
Net Change In Cash $8.830M 553.0K -3.661M
YoY Change -341.19% -154.0% -162.8%
FREE CASH FLOW
Cash From Operating Activities $290.0K -$12.00K $1.395M
Capital Expenditures $3.000K
Free Cash Flow $287.0K $1.395M
YoY Change -79.43% -131.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0000797465
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34404556
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q3 dei Entity Public Float
EntityPublicFloat
13600000
CY2020 dei Entity Registrant Name
EntityRegistrantName
HG Holdings, Inc.
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Security12g Title
Security12gTitle
Common Stock, par value $.02 per share, Preferred Stock Purchase Rights
CY2020 dei Trading Symbol
TradingSymbol
stly
CY2020Q4 stly Deferred Tax Assets Note Receivable Fair Value Adjustment
DeferredTaxAssetsNoteReceivableFairValueAdjustment
319000
CY2019Q4 stly Deferred Tax Assets Note Receivable Fair Value Adjustment
DeferredTaxAssetsNoteReceivableFairValueAdjustment
578000
CY2020Q4 stly Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Current
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCurrent
50000
CY2019Q4 stly Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Current
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCurrent
65000
CY2020Q4 stly Deferred Tax Liabilities Nontaxable Dividends
DeferredTaxLiabilitiesNontaxableDividends
193000
CY2019Q4 stly Deferred Tax Liabilities Nontaxable Dividends
DeferredTaxLiabilitiesNontaxableDividends
CY2020 stly Dividends On Investment In Affiliate
DividendsOnInvestmentInAffiliate
200000
CY2019 stly Dividends On Investment In Affiliate
DividendsOnInvestmentInAffiliate
150000
CY2020 stly Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0.023
CY2019 stly Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
CY2020 stly Effective Income Tax Rate Reconciliation Provision To Return Adjustments Percent
EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsPercent
3.604
CY2019 stly Effective Income Tax Rate Reconciliation Provision To Return Adjustments Percent
EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentsPercent
-0.039
CY2020 stly Gain Loss On Extinguishment Of Note Receivable
GainLossOnExtinguishmentOfNoteReceivable
1326000
CY2019 stly Gain Loss On Extinguishment Of Note Receivable
GainLossOnExtinguishmentOfNoteReceivable
CY2020 stly Gain Loss On Sale Of Closely Held Stock
GainLossOnSaleOfCloselyHeldStock
CY2019 stly Gain Loss On Sale Of Closely Held Stock
GainLossOnSaleOfCloselyHeldStock
120000
CY2020 stly Impairment Of Notes Receivable
ImpairmentOfNotesReceivable
833000
CY2019 stly Impairment Of Notes Receivable
ImpairmentOfNotesReceivable
897000
CY2020 stly Income From Continued Dumping And Subsidy Offset Act Net
IncomeFromContinuedDumpingAndSubsidyOffsetActNet
0
CY2019 stly Income From Continued Dumping And Subsidy Offset Act Net
IncomeFromContinuedDumpingAndSubsidyOffsetActNet
1230000
CY2020 stly Income Tax Rate Reconciliation Alternative Minimum Tax Percent
IncomeTaxRateReconciliationAlternativeMinimumTaxPercent
-3.597
CY2019 stly Income Tax Rate Reconciliation Alternative Minimum Tax Percent
IncomeTaxRateReconciliationAlternativeMinimumTaxPercent
-1.227
CY2020Q4 stly Interest And Dividends Receivable Current
InterestAndDividendsReceivableCurrent
298000
CY2019Q4 stly Interest And Dividends Receivable Current
InterestAndDividendsReceivableCurrent
91000
CY2020 stly Paidinkind Interest From Notes Receivable
PaidinkindInterestFromNotesReceivable
-25000
CY2019 stly Paidinkind Interest From Notes Receivable
PaidinkindInterestFromNotesReceivable
CY2020 stly Proceeds From Sale Of Closely Held Stock
ProceedsFromSaleOfCloselyHeldStock
CY2019 stly Proceeds From Sale Of Closely Held Stock
ProceedsFromSaleOfCloselyHeldStock
120000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
104000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
217000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29738000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
17370000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
83000
CY2020Q4 us-gaap Assets
Assets
27026000
CY2019Q4 us-gaap Assets
Assets
14334000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
12555000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
3802000
CY2020Q4 us-gaap Cash
Cash
11396000
CY2019Q4 us-gaap Cash
Cash
2567000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11630000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2800000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2800000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6461000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11630000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8830000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3661000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34404556
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14946839
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34404556
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14946839
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
684000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
294000
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risk</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company place its cash and restricted cash with financial institutions and, at times, cash held in depository accounts <div style="display: inline; font-style: italic; font: inherit;"> may </div>exceed the Federal Deposit Insurance Corporation insured limit.</div></div></div></div></div>
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-247000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-247000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-84000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-84000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
247000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
247000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
247000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
8469000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
8500000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2020Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
11000
CY2019Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
CY2020Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
195000
CY2019Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
99000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8469000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8747000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7861000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7726000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
247000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
33000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
32000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8275000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8499000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1000
CY2020 us-gaap Depreciation
Depreciation
3000
CY2019 us-gaap Depreciation
Depreciation
2000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.01
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.976
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.24
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.043
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.001
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
86000
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.038
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5000
CY2020 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
165000
CY2019 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
124000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
12072000
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
4405000
CY2020 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
833000
CY2019 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
897000
CY2020Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
1000000
CY2020 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
63000
CY2019 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
170000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-418000
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-430000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-84000
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
488000
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
735000
CY2019Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
2000000
CY2020 us-gaap Open Tax Year
OpenTaxYear
2013 2014 2015 2016 2017 2018 2019
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-1304000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-1133000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-22000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-113000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
46000
CY2020 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-247000
CY2019 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
247000
CY2020 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
207000
CY2019 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-232000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-232000
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-12000
CY2019 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-32000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-37000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-47000
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
417000
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
430000
CY2020 us-gaap Investment Income Dividend
InvestmentIncomeDividend
684000
CY2019 us-gaap Investment Income Dividend
InvestmentIncomeDividend
157000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
608000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
1039000
CY2020Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
230000
CY2020Q4 us-gaap Liabilities
Liabilities
306000
CY2019Q4 us-gaap Liabilities
Liabilities
435000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27026000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14334000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
63000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
180000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12675000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4135000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5056000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
290000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1395000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
170000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
63000
CY2020Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1883000
CY2019Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
3379000
CY2018Q1 us-gaap Notes Receivable Net
NotesReceivableNet
7400000
CY2020Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
168000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
58000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
509000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
494000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
243000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
255000
CY2020 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
CY2019 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
2000000
CY2020 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
8250000
CY2019 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
5000000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
139000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
176000
CY2020 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
2000000
CY2019 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
CY2020 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
2118000
CY2019 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1824000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12675000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
234000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
233000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
234000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
233000
CY2020 us-gaap Restricted Stock Expense
RestrictedStockExpense
83000
CY2019 us-gaap Restricted Stock Expense
RestrictedStockExpense
85000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3702000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3765000
CY2020 us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Interest Income</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Interest income is recorded on an accrual basis based on the effective interest rate method and includes the accretion of fair value adjustments/discounts. Fair value adjustments to par value are accreted/amortized into interest income over the life of the respective security using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of fair value adjustments, if any.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Other revenues are recognized when contractual obligations are fulfilled or as services are provided.</div></div></div></div></div>
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1133000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6212
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1304000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
20914
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
36071
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
63197
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
42283
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.01
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.20
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.01
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
8.64
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.54
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y292D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P292D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12675000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
26720000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
13899000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
13644000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
157000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
241000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
157000
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
84000
CY2020Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
157000
CY2019Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
157000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Use of Estimates </div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.&nbsp; Changes in such estimates <div style="display: inline; font-style: italic; font: inherit;"> may </div>affect amounts reported in future periods.</div></div></div></div></div>
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
226000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25421000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14937000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25004000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14507000

Files In Submission

Name View Source Status
0001437749-21-004617-index-headers.html Edgar Link pending
0001437749-21-004617-index.html Edgar Link pending
0001437749-21-004617.txt Edgar Link pending
0001437749-21-004617-xbrl.zip Edgar Link pending
ex_227510.htm Edgar Link pending
ex_227511.htm Edgar Link pending
ex_227512.htm Edgar Link pending
ex_227513.htm Edgar Link pending
ex_227514.htm Edgar Link pending
ex_227515.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stly-20201231.xml Edgar Link completed
stly-20201231.xsd Edgar Link pending
stly-20201231_cal.xml Edgar Link unprocessable
stly-20201231_def.xml Edgar Link unprocessable
stly-20201231_lab.xml Edgar Link unprocessable
stly-20201231_pre.xml Edgar Link unprocessable
stly20201231_10k.htm Edgar Link pending